190 related articles for article (PubMed ID: 7519824)
1. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival.
Campo E; Muñoz J; Miquel R; Palacín A; Cardesa A; Sloane BF; Emmert-Buck MR
Am J Pathol; 1994 Aug; 145(2):301-9. PubMed ID: 7519824
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin B and tumor-associated laminin expression in the progression of colorectal adenoma to carcinoma.
Khan A; Krishna M; Baker SP; Banner BF
Mod Pathol; 1998 Aug; 11(8):704-8. PubMed ID: 9720496
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the 67-kD laminin receptor correlates with tumour progression in human colorectal carcinoma.
Sanjuán X; Fernández PL; Miquel R; Muñoz J; Castronovo V; Ménard S; Palacín A; Cardesa A; Campo E
J Pathol; 1996 Aug; 179(4):376-80. PubMed ID: 8869283
[TBL] [Abstract][Full Text] [Related]
4. Elevations in cathepsin B protein content and enzyme activity occur independently of glycosylation during colorectal tumor progression.
Iacobuzio-Donahue CA; Shuja S; Cai J; Peng P; Murnane MJ
J Biol Chem; 1997 Nov; 272(46):29190-9. PubMed ID: 9360997
[TBL] [Abstract][Full Text] [Related]
5. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas.
Shuja S; Sheahan K; Murnane MJ
Int J Cancer; 1991 Sep; 49(3):341-6. PubMed ID: 1917131
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin B and cathepsin D expression in the progression of colorectal adenoma to carcinoma.
Talieri M; Papadopoulou S; Scorilas A; Xynopoulos D; Arnogianaki N; Plataniotis G; Yotis J; Agnanti N
Cancer Lett; 2004 Mar; 205(1):97-106. PubMed ID: 15036666
[TBL] [Abstract][Full Text] [Related]
8. Comparative localization of cathepsin B protein and activity in colorectal cancer.
Hazen LG; Bleeker FE; Lauritzen B; Bahns S; Song J; Jonker A; Van Driel BE; Lyon H; Hansen U; Köhler A; Van Noorden CJ
J Histochem Cytochem; 2000 Oct; 48(10):1421-30. PubMed ID: 10990495
[TBL] [Abstract][Full Text] [Related]
9. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.
Kataoka H; Hamasuna R; Itoh H; Kitamura N; Koono M
Cancer Res; 2000 Nov; 60(21):6148-59. PubMed ID: 11085539
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cathepsin X in colorectal cancer development and progression.
Jechorek D; Votapek J; Meyer F; Kandulski A; Roessner A; Franke S
Pathol Res Pract; 2014 Dec; 210(12):822-9. PubMed ID: 25442015
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of galectin 3 and galectin 1 in colorectal cancer progression.
Sanjuán X; Fernández PL; Castells A; Castronovo V; van den Brule F; Liu FT; Cardesa A; Campo E
Gastroenterology; 1997 Dec; 113(6):1906-15. PubMed ID: 9394730
[TBL] [Abstract][Full Text] [Related]
12. Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
de Wit M; Carvalho B; Delis-van Diemen PM; van Alphen C; Beliën JAM; Meijer GA; Fijneman RJA
PLoS One; 2017; 12(5):e0174768. PubMed ID: 28481899
[TBL] [Abstract][Full Text] [Related]
13. Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa.
Nozawa Y; Van Belzen N; Van der Made AC; Dinjens WN; Bosman FT
J Pathol; 1996 Jan; 178(1):48-52. PubMed ID: 8778315
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of metallothionein in normal human colorectal mucosa, in adenomas and in adenocarcinomas and their associated metastases.
Giuffrè G; Barresi G; Sturniolo GC; Sarnelli R; D'Incà R; Tuccari G
Histopathology; 1996 Oct; 29(4):347-54. PubMed ID: 8910042
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of decorin expression in polyps and carcinomas of the colon.
Augoff K; Rabczynski J; Tabola R; Czapla L; Ratajczak K; Grabowski K
Med Sci Monit; 2008 Oct; 14(10):CR530-5. PubMed ID: 18830193
[TBL] [Abstract][Full Text] [Related]
16. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Kim H; Kang HJ; You KT; Kim SH; Lee KY; Kim TI; Kim C; Song SY; Kim HJ; Lee C; Kim H
Proteomics; 2006 Jun; 6(11):3466-76. PubMed ID: 16645984
[TBL] [Abstract][Full Text] [Related]
17. Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas.
del Re EC; Shuja S; Cai J; Murnane MJ
Br J Cancer; 2000 Apr; 82(7):1317-26. PubMed ID: 10755408
[TBL] [Abstract][Full Text] [Related]
18. Cellular localisation of c-myc product in human colorectal epithelial neoplasia.
Royds JA; Sharrard RM; Wagner B; Polacarz SV
J Pathol; 1992 Mar; 166(3):225-33. PubMed ID: 1381423
[TBL] [Abstract][Full Text] [Related]
19. Expression profile of mucin-associated sialyl-Tn antigen in Chinese patients with different colorectal lesions (adenomas, carcinomas).
Xu F; Fan C; Fan S; Liu F; Wen T; An G; Feng G
Int J Clin Exp Pathol; 2015; 8(9):11549-54. PubMed ID: 26617889
[TBL] [Abstract][Full Text] [Related]
20. Expression of insulin-like growth factor-1 receptor in human colorectal cancer.
Hakam A; Yeatman TJ; Lu L; Mora L; Marcet G; Nicosia SV; Karl RC; Coppola D
Hum Pathol; 1999 Oct; 30(10):1128-33. PubMed ID: 10534157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
